Drugs / Inactivated, split-virion influenza vaccine
Inactivated, split-virion influenza vaccine
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials · 1 met primary | ||||||
| Phase 2 | NCT00296829 | Jan 2006 → Feb 2007 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | Met primary |
| Phase 2 | NCT00258934 | Sep 2005 → Jun 2008 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 31 trial · 1 met primary | ||||||
| Phase 3 | NCT00391053 | Oct 2006 → Jul 2007 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | Met primary |
| Phase not applicable1 trial | ||||||
| — | NCT01465477 | Nov 2011 → Jun 2012 | fibromyalgia | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 2 | NCT00703651 Comparator | Sep 2003 → May 2006 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 3 | NCT00383526 Comparator | Sep 2006 → Jun 2009 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 3 | NCT00383539 Comparator | Sep 2006 → Jul 2007 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated, split-virion influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00703651 ↗ |
| Modality | Vaccine | “Inactivated, split-virion influenza vaccine” NCT00258934 ↗ |
| Route | Intramuscular | “0.5 mL, IM” NCT00391053 ↗ |